Identification and Functional Validation of Differentially Expressed microRNAs in Ascites-Derived Ovarian Cancer Cells Compared with Primary Tumour Tissue

References

• KimS, KimB, SongYS. Ascites modulates cancer cell behavior, contributing to tumor heterogeneity in ovarian cancer. Cancer Sci. 2016;107(9):1173–1178. doi:10.1111/cas.1298727297561
   PubMed Web of Science ®Google Scholar
• BapatSA, JinV, BerryN, et al. Multivalent epigenetic marks confer microenvironment-responsive epigenetic plasticity to ovarian cancer cells. Epigenetics. 2010;5(8):716–729. doi:10.4161/epi.5.8.1301420676026
   PubMed Web of Science ®Google Scholar
• DebB, UddinA, ChakrabortyS. miRNAs and ovarian cancer: an overview. J Cell Physiol. 2018;233(5):3846–3854. doi:10.1002/jcp.2609528703277
   PubMed Web of Science ®Google Scholar
• HeWA, CaloreF, LondheP, CanellaA, GuttridgeDC, CroceCM. Microvesicles containing miRNAs promote muscle cell death in cancer cachexia via TLR7. Proc Natl Acad Sci U S A. 2014;111(12):4525–4529. doi:10.1073/pnas.140271411124616506
   PubMed Web of Science ®Google Scholar
• BarrettT, WilhiteSE, LedouxP, et al. NCBI GEO: archive for functional genomics data sets–update. Nucleic Acids Res. 2013;41(Database issue):D991–D995. doi:10.1093/nar/gks119323193258
   PubMed Web of Science ®Google Scholar
• ChouCH, ShresthaS, YangCD, et al. miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions. Nucleic Acids Res. 2018;46(D1):D296–d302. doi:10.1093/nar/gkx106729126174
   PubMed Web of Science ®Google Scholar
• AgarwalV, BellGW, NamJW, BartelDP. Predicting effective microRNA target sites in mammalian mRNAs. eLife. 2015;4:e05005. doi:10.7554/eLife.05005
   PubMed Web of Science ®Google Scholar
• ShermanBT, LempickiRA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44–57. doi:10.1038/nprot.2008.21119131956
   PubMed Web of Science ®Google Scholar
• SzklarczykD, FranceschiniA, KuhnM, et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res. 2011;39(Databaseissue):D561–D568. doi:10.1093/nar/gkq97321045058
   PubMed Web of Science ®Google Scholar
• TongZ, CuiQ, WangJ, ZhouY. TransmiR v2.0: an updated transcription factor-microRNA regulation database. Nucleic Acids Res. 2019;47(D1):D253–d258. doi:10.1093/nar/gky102330371815
   PubMed Web of Science ®Google Scholar
• FarréD, RosetR, HuertaM, et al. Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN. Nucleic Acids Res. 2003;31(13):3651–3653. doi:10.1093/nar/gkg60512824386
   PubMed Web of Science ®Google Scholar
• StaicuCE, PredescuDV, RusuCM, et al. Role of microRNAs as clinical cancer biomarkers for ovarian cancer: a short overview. Cells. 2020;9(1):169. doi:10.3390/cells9010169
   PubMed Web of Science ®Google Scholar
• NamEJ, YoonH, KimSW, et al. MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res. 2008;14(9):2690–2695. doi:10.1158/1078-0432.CCR-07-173118451233
   PubMed Web of Science ®Google Scholar
• CuiY, WuF, TianD, et al. miR-199a-3p enhances cisplatin sensitivity of ovarian cancer cells by targeting ITGB8. Oncol Rep. 2018;39(4):1649–1657.29436681
   PubMed Web of Science ®Google Scholar
• DengY, ZhaoF, HuiL, et al. Suppressing miR-199a-3p by promoter methylation contributes to tumor aggressiveness and cisplatin resistance of ovarian cancer through promoting DDR1 expression. J Ovarian Res. 2017;10(1):50. doi:10.1186/s13048-017-0333-428743276
   PubMed Web of Science ®Google Scholar
• KinoseY, SawadaK, NakamuraK, et al. The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma. Oncotarget. 2015;6(13):11342–11356. doi:10.18632/oncotarget.360425839163
   PubMed Web of Science ®Google Scholar
• LiuX, YaoB, WuZ. miRNA-199a-5p suppresses proliferation and invasion by directly targeting NF-κB1 in human ovarian cancer cells. Oncol Lett. 2018;16(4):4543–4550.30214589
   PubMed Web of Science ®Google Scholar
• XiangG, ChengY. MiR-126-3p inhibits ovarian cancer proliferation and invasion via targeting PLXNB2. Reprod Biol. 2018;18(3):218–224. doi:10.1016/j.repbio.2018.07.00530054097
   PubMed Web of Science ®Google Scholar
• GanX, ZhuH, JiangX, et al. CircMUC16 promotes autophagy of epithelial ovarian cancer via interaction with ATG13 and miR-199a. Mol Cancer. 2020;19(1):45. doi:10.1186/s12943-020-01163-z32111227
   PubMed Web of Science ®Google Scholar
• LiuHZ, LiuGY, PangWW, ZhangH, ZengZJ, WangHJ. LncRNA LUCAT1 promotes proliferation of ovarian cancer cells by regulating miR-199a-5p expression. Eur Rev Med Pharmacol Sci. 2020;24(4):1682–1687.32141534
   PubMed Web of Science ®Google Scholar
• XuC, ZhuLX, SunDM, YaoH, HanDX. Regulatory mechanism of lncRNA NORAD on proliferation and invasion of ovarian cancer cells through miR-199a-3p. Eur Rev Med Pharmacol Sci. 2020;24(4):1672–1681.32141533
   PubMed Web of Science ®Google Scholar
• PanC, StevicI, MüllerV, et al. Exosomal microRNAs as tumor markers in epithelial ovarian cancer. Mol Oncol. 2018;12(11):1935–1948. doi:10.1002/1878-0261.1237130107086
   PubMed Web of Science ®Google Scholar
• LiangH, JiangZ, XieG, LuY. Serum microRNA-145 as a novel biomarker in human ovarian cancer. Tumour Biol. 2015;36(7):5305–5313. doi:10.1007/s13277-015-3191-y25722112
   PubMedGoogle Scholar
• HuaM, QinY, ShengM, et al. miR‑145 suppresses ovarian cancer progression via modulation of cell growth and invasion by targeting CCND2 and E2F3. Mol Med Rep. 2019;19(5):3575–3583.30864742
   PubMed Web of Science ®Google Scholar
• ChenX, DongC, LawPT, et al. MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer. Gynecol Oncol. 2015;139(3):513–519. doi:10.1016/j.ygyno.2015.10.00826472353
   PubMed Web of Science ®Google Scholar
• LiJ, ZhangS, WuL, PeiM. Interaction between LncRNA-ROR and miR-145 contributes to epithelial-mesenchymal transition of ovarian cancer cells. Gen Physiol Biophys. 2019;38(6):461–471. doi:10.4149/gpb_201902831829305
   PubMed Web of Science ®Google Scholar
• HuJ, WangL, ChenJ, et al. The circular RNA circ-ITCH suppresses ovarian carcinoma progression through targeting miR-145/RASA1 signaling. Biochem Biophys Res Commun. 2018;505(1):222–228. doi:10.1016/j.bbrc.2018.09.06030243714
   PubMed Web of Science ®Google Scholar
• ShieldK, AcklandML, AhmedN, RiceGE. Multicellular spheroids in ovarian cancer metastases: biology and pathology. Gynecol Oncol. 2009;113(1):143–148. doi:10.1016/j.ygyno.2008.11.03219135710
   PubMed Web of Science ®Google Scholar
• LyuT, JiangY, JiaN, et al. SMYD3 promotes implant metastasis of ovarian cancer via H3K4 trimethylation of integrin promoters. Int J Cancer. 2020;146:1553–1567.31503345
   PubMed Web of Science ®Google Scholar
• TangMK, ZhouHY, YamJW, WongAS. c-Met overexpression contributes to the acquired apoptotic resistance of nonadherent ovarian cancer cells through a cross talk mediated by phosphatidylinositol 3-kinase and extracellular signal-regulated kinase 1/2. Neoplasia. 2010;12(2):128–138. doi:10.1593/neo.9143820126471
   PubMed Web of Science ®Google Scholar
• GuS, CheungHH, LeeTL, LuG, PoonWS, ChanWY. Molecular mechanisms of regulation and action of microRNA-199a in testicular germ cell tumor and glioblastomas. PLoS One. 2013;8(12):e83980. doi:10.1371/journal.pone.008398024391856
   PubMed Web of Science ®Google Scholar
• SumigamaS, ItoT, KajiyamaH, et al. Suppression of invasion and peritoneal carcinomatosis of ovarian cancer cells by overexpression of AP-2alpha. Oncogene. 2004;23(32):5496–5504. doi:10.1038/sj.onc.120772315146170
   PubMed Web of Science ®Google Scholar